Viking Therapeutics
VKTX
#2507
Rank
HK$44.77 B
Marketcap
HK$401.76
Share price
0.19%
Change (1 day)
354.07%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -HK$0.78 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$0.67 Billion a decrease over its 2022 earnings that were of -HK$0.54 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.78 Billion15.78%
2023 -HK$0.67 Billion24.73%
2022 -HK$0.54 Billion25.24%
2021 -HK$0.43 Billion39.23%
2020 -HK$0.31 Billion53.21%
2019 -HK$0.21 Billion16.84%
2018 -HK$0.18 Billion7.22%
2017 -HK$0.17 Billion39.68%
2016 -HK$0.12 Billion-37.05%
2015 -HK$0.19 Billion6.94%
2014 -HK$0.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$4.05 Billion 424.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.28 M-103.80%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.16 B-121.64%๐Ÿ‡บ๐Ÿ‡ธ USA